Product R&D for neglected diseases. Twenty-seven years of WHO/TDR experiences with public-private partnerships
about
Future trends and challenges in pathogenomics. A Foresight study.Virtual drug discovery and development for neglected diseases through public-private partnerships.Praziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.Advances in the discovery and development of trematocidal drugs.Research on infectious diseases requires better coordination.Making a difference: 30 years of TDR.
P2860
Product R&D for neglected diseases. Twenty-seven years of WHO/TDR experiences with public-private partnerships
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Product R&D for neglected dise ...... th public-private partnerships
@ast
Product R&D for neglected dise ...... th public-private partnerships
@en
Product R&D for neglected dise ...... th public-private partnerships
@nl
type
label
Product R&D for neglected dise ...... th public-private partnerships
@ast
Product R&D for neglected dise ...... th public-private partnerships
@en
Product R&D for neglected dise ...... th public-private partnerships
@nl
prefLabel
Product R&D for neglected dise ...... th public-private partnerships
@ast
Product R&D for neglected dise ...... th public-private partnerships
@en
Product R&D for neglected dise ...... th public-private partnerships
@nl
P2860
P1433
P1476
Product R&D for neglected dise ...... th public-private partnerships
@en
P2093
Robert G Ridley
P2860
P356
10.1038/SJ.EMBOR.EMBOR858
P478
P577
2003-06-01T00:00:00Z